Rockwell Medical (RMTI)
(Delayed Data from NSDQ)
$1.33 USD
0.00 (0.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.34 +0.01 (0.75%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RMTI 1.33 0.00(0.00%)
Will RMTI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RMTI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RMTI
Rockwell Medical (RMTI) Is Attractively Priced Despite Fast-paced Momentum
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
RMTI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates
VAREX IMAGING (VREX) Surpasses Q3 Earnings and Revenue Estimates
Other News for RMTI
50 Day Moving Average Support appears for RMTI after 17.39% move
RMTI's price falls by 4.17% on September 18, though its technical setup remains stable.
Is RMTI ready to move higher? 1,2,3 Pullback Bullish shows up after climbing 1.2%
1,2,3 Pullback Bullish appears for RMTI after 2.47% move
The technical outlook for RMTI is unchanged after it falls 4.14% on September 12